Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative therapies function by mimicking the inherent actions of GLP-1, a hormone released by https://thebookmarkid.com/story20882702/reta-glucagon-like-peptide-1-receptor-agonists